Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Medivation: Better On Its Own?
Barron's
Fri, 05/6/16 - 10:58 am
Medivation
M&A
Sanofi
Pfizer
Amgen
Sanofi, Amgen cholesterol drugs win UK backing after price cuts
Yahoo/Reuters
Fri, 05/6/16 - 10:47 am
Sanofi
Amgen
UK
PCSK9 inhibitors
Repatha
Praluent
Amgen Said to Join Health-Care Pack Weighing Medivation Bids
Bloomberg
Thu, 05/5/16 - 02:06 pm
Amgen
Sanofi
Pfizer
Medivation
M&A
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
Regeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race
Seeking Alpha
Tue, 05/3/16 - 09:46 pm
Regeneron
Amgen
Pfizer
painkillers
fasinumab
clinical trials
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead
Forbes
Sat, 04/30/16 - 11:40 am
Amgen
Biogen
Celgene
Gilead Sciences
earnings
Amgen beats Street 1Q forecasts
Yahoo/AP
Thu, 04/28/16 - 06:05 pm
Amgen
earnings
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Roche
ASCO
immuno-oncology
Amgen
Merck
Bristol-Myers Squibb
Amgen (AMGN): What to Expect from Q1 Earnings
Bidness, ETC
Sun, 04/24/16 - 12:02 pm
Amgen
earnings
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Humira
Amgen
Bristol-Myers Squibb
Coherus Biosciences
Gilead Sciences
Intercept Pharma
JNJ
Novartis
Pfizer
New heart drugs struggle to win sales as doctors hold back
Yahoo/Reuters
Thu, 04/21/16 - 09:16 am
Novartis
Entresto
Sanofi
Amgen
Praluent
Repatha
physicians
Why Biotech Will Benefit from Higher Drug Prices
Barron's
Wed, 04/20/16 - 06:41 pm
biotech
drug pricing
JNJ
Gilead Sciences
Amgen
Biogen
Medivation: Biotech’s Most Wanted?
Barron's
Wed, 04/13/16 - 09:53 am
Medivation
M&A
Amgen
Gilead Sciences
Sanofi
AstraZeneca
Biotech: If M&A is the Answer, What’s the Question?
Barron's
Tue, 04/12/16 - 03:42 pm
biotech
M&A
Amgen
Biogen
Celgene
Gilead Sciences
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Big year at Amgen delivers $2M pay hike for CEO Bradway, to $16M
Fierce Pharma
Mon, 04/11/16 - 05:17 pm
Amgen
Bob Bradway
Pharma CEOs
executive pay
Amgen balks over meeting to review cost of bone cancer drugs
Stat
Thu, 04/7/16 - 09:46 am
Amgen
drug pricing
Kyprolis
Multiple Myeloma
Why Gilead Sciences and Amgen Can Eye Medivation As Acquisition Target
Bidness, ETC
Tue, 04/5/16 - 08:48 am
Gilead Sciences
Amgen
Medivation
M&A
That blockbuster anti-NGF pain drug fulranumab? J&J doesn't want it anymore
Fierce Biotech
Fri, 04/1/16 - 10:10 am
JNJ
fulranumab
anti-NGF
painkillers
Amgen
Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in
Fierce Pharma
Thu, 03/31/16 - 09:39 pm
Supreme Court
Sandoz
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »